Increasing Global Use in Diabetes and Weight Management Adoption has surged globally due to its dual benefit profile: Robust glycemic control Clinically meaningful weight reduction Cardioprotective potential Composition and Formulation Details Active Ingredient: Semaglutide and Its Pharmacological Profile Semaglutide is a long-acting GLP-1 analog with structural modifications that confer resistance to enzymatic degradation
As a GLP-1 receptor agonist, semaglutide mimics the incretin hormone GLP-1, increasing insulin release, decreasing glucagon levels, and slowing gastric emptying
Negative Thought Spirals (01:36:16) Tool: Phone & To Dont List
A large 2022 trial that monitored digestive side effects found a median duration of constipation of 47 days in people on semaglutide, compared with 35 days on placebo, suggesting the effect often persists for weeks during dose escalation and early maintenance
Before starting Semaglu 0.25/0.5 Pre-filled Pen, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems
Important Note Persistent vomiting, severe abdominal pain, or symptoms of pancreatitis require immediate medical evaluation